Functional and growth properties of a myometrial cell line derived from transgenic mice: Effects of estradiol and antiestrogens

Endocrinology

Volumn 137, Issue 6, 1996, Pages 2246-2253

  Blin, Claudine ^a   L'Horset, Fabienne ^a   Romagnolo, Béatrice ^b   Colnot, Sabine ^a   Lambert, Mireille ^a   Thomasset, Monique ^a   Kahn, Axel ^b   Vandewalle, Alain ^c   Perret, Christine ^a,b,c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; ESTROGEN; VIRUS LARGE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ESTRUS CYCLE; GENE EXPRESSION; LEIOMYOMA; MOUSE; MYOMETRIUM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SIMIAN VIRUS 40; TRANSGENIC MOUSE;

EID: 0030011051     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.6.8641172     Document Type: Article

References (45)

1. Brody JR, Cunha GR 1989 Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice. I. Normal development. Am J Anat 186:1-20
2. Brody JR, Cunha GR 1989 Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice. II. Effects of DES on development. Am J Anat 186:21-42
3. Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K 1985 Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing estrogen and progesterone receptor. Nippon Sanka Fujinka Gakkai Zasshi (Jpn) 37:1103-1111
4. Wiehle RD, Helftenbein G, Land H, Neumann K, Beato M 1990 Establishment of rat endometrial cell lines by retroviral mediated transfer of immortalizing and transforming oncogenes. Oncogene 5:787-794
5. Helfenbein G, Alvarez CV, Tuohimaa P, Beato M 1993 Expression of epithelial phenotype is enhanced by v-Ha-ras in rat endometrial cells immortalized by SV40 T antigen. Oncogene 8:2075-2085
6. Riemer RK, Sadovsky Y, Roberts JM 1993 Myometrial characteristics of the Syrian hamster uterine smooth muscle cell line, SHM, in vitro. Cell Dev Biol 29A:478-480
7. Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK 1992 Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci USA 89:1224-1228
8. Hanahan D 1988 Dissecting multistep tumorigenesis in transgenic mice. Annu Rev Genet 22:479-519
9. Briand P, Kahn A, Vandewalle A 1995 Targeted oncogenesis: a powerful method to derive renal cell lines. Kidney Int 47:388-394
10. Delorme AC, Danan JL, Acker MG, Ripoche MA, Mathieu H 1983 In rat uterus 17β-estradiol stimulates a calcium binding protein similar to the duodenal vitamin D-dependent calcium binding protein. Endocrinology 113:1340-1347
11. Bruns ME, Overpeck JG, Smith GC, Hirsch GN, Mills SE, Bruns DE 1988 Vitamin D-dependent calcium binding protein in rat uterus: differential effects of estrogen, tamoxifen, progesterone and pregnancy on accumulation and cellular localization. Endocrinology 122: 2371-2378
12. Mathieu CL, Burnett SH, Mills SE, Overpeck JG, Bruns DE, Bruns ME 1989 Gestational changes in calbindin-D9k in rat uterus, yolk sac, and placenta: implications for maternal-fetal calcium transport and uterine muscle function. Proc Natl Acad Sci USA 86:3433-3437
13. Warembourg M, Perret C, Thomasset M 1987 Analysis and in situ detection of cholecalcin messenger RNA (9000 Mr CaBP) in the uterus of the pregnant rat. Cell Tissue Res 247:51-57
14. L'Horset F, Perret C, Brehier A, Thomasset M 1990 17β-estradiol stimulates the calbindin-D9K (CaBP9K) gene expression at the transcriptional and post-transcriptional levels in the rat uterus. Endocrinology 127:2891-2897
15. L'Horset F, Blin C, Bréhier A, Thomasset M, Perret C 1993 Estrogen-induced calbindin-D 9k gene expression in the rat uterus during the estrous cycle: late antagonistic effect of progesterone. Endocrinology 132:489-495
16. Darwish H, Krisinger J, Furlow JD, Smith C, Murdoch FE, DeLuca HF 1991 An estrogen-responsive element mediates the transcriptional regulation of calbindin D-9K gene in rat uterus. J Biol Chem 266:551-558
17. L'Horset F, Blin C, Colnot S, Lambert M, Thomasset M, Perret C 1994 Calbindin-D 9k gene expression in the rat uterus: study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element. Endocrinology 134:11-18
18. Blin C, L'Horset F, Leclerc T, Lambert M, Colnot S, Thomasset M, Perret C 1995 Contrasting effects of tamoxifen and ICI 182780 on estrogen-induced calbindin-D9k gene expression in the uterus and in primary culture of myometrial cells. J Steroid Biochem Mol Biol 55:1-7
19. Lacave R, Bens M, Cartier N, Vallet V, Robine S, Pringault E, Kahn A, Vandewalle A 1993 Functional properties of proximal tubule cell lines derived from transgenic mice harboring L-pyruvate kinase-SV40 (T) antigen hybrid gene. J Cell Sci 104:705-712
20. Chomczynski P, Sacchi M 1987 Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-159
21. Perret C, Desplan C, Brehier A, Thomasset M 1985 Characterization of rat 9-kDa cholecalcin (CaBP) messenger RNA using a complementary DNA: absence of homology with 28-kDa cholecalcin mRNA. Eur J Biochem 148:61-66
22. Hsu CJ, Komm BS, Lyttle CR, Frankel F 1988 Cloning of estrogen-regulated messenger ribonucleic acids from rat uterus. Endocrinology 122:631-639
23. Schneider W, Ramachandran C, Satyaswaroop PG, Shyamala G 1991 Murine progesterone receptor exists predominantly as the 83-kilodalton "A" form. J Steroid Biochem Mol Biol 38:285-291
24. Wakeling AE, Bowler J 1988 Biology and mode of action of pure antioestrogens. J Steroid Biochem 30:141-147
25. Gibson MK, Nemmers LA, Beckman WC, Davis VI, Curtis SW, Korach KS 1991 The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129:2000-2010
26. Lippman ME, Bolan G, Huff K 1976 The effect of estrogens on hormone responsive human breast cancer tissue culture. Cancer Res 36:4595-4601
27. Rochefort H, Bardon S, Chalbos D, Vignon F 1984 Steroidal and non steroidal antiestrogens in breast cancer cells in culture. J Steroid Biochem 20:105-110
28. Katzenellenbogen BS, Miller MA, Mullick A, Sheen YY 1985 Antiestrogen action in breast cancer cell: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites. Breast Cancer Res Treat 5:231-243
29. Bardon S, Vignon F, Montcourrier P, Rochefort H 1987 Steroid receptor-mediated cytotoxicity of an antiestrogen and antiprogestin in breast cancer. Cancer Res 47:1441-1448
30. Jordan VC, Murphy CS 1990 Endocrine pharmacology of antiestrogens as antitumor agents. Endocr Rev 11:578-612
31. Jordan VC, Dix CJ, Naylor KE, Prestwich G, Rowsby L 1978 Non-steroidal antiestrogens: their biological effects and potential mechanisms of action. J Toxicol Environ Health 4:363-390
32. Wakeling AE, Dukes M, Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Res 51:3867-3873
33. Vignon F, Bouton MM, Rochefort H 1987 Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem Biophys Res Commun 146:1502-1508
34. Rochefort H 1987 Do antiestrogens and antiprogestins act as hormone antagonists or receptor-targeted drugs in breast cancer? Trends Pharmacol Sci 8:126-128
35. Pietras RJ, Arboleda J, Reese DM, Wongvipat N, Pegram MD, Ramos L, Gorman CM, Parker MG, Sliwkowski MX, Slamon DJ 1995 HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene 10:2435-2446
36. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, Korach KS 1992 Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662
37. Smith CL, Conneely OM, O'Malley BW 1993 Modulation of ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124
38. Tenniswood MP, Guenette RS, Lakins J, Mooibroeck M, Wong P, Welsh JE 1992 Active cell death in hormone-dependent tissues. Cancer Metast Rev 11:197-220
39. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB 1987 Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428
40. Darbre PD, Daly RJ 1990 Transition of human breast cancer cells from an oestrogen responsive to unresponsive state. J Steroid Biochem Mol Biol 37:753-763
41. Lippman AE, Dickson RB 1989 Mechanisms of growth normal and malignant breast epithelium. Recent Prog Horm Res 45:383-440
42. Karnik PS, Kulkami S, Liu XP, Budd GT, Bukowski RM 1994 Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res 54:349-353
43. Clarke E, Skaar T, Baumann K, Leonessa F, James M, Lippman J, Thompson EW, Frter C, Brunner N 1994 Hormonal carcinogenesis in breast cancer: cellular and molecular studies of malignant progression. Breast Cancer Res Treat 31:237-248
44. Aronica SM, Katzenellenbogen BS 1993 Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor, cyclic adenosine monophosphate and insulin-like growth factor-I. Mol Endocrinol 7:743-752
45. Wright C, Nicholson S, Angus B, Sainsbury JR, Farndon J, Cairns J, Harris AL, Home CH 1992 Br J Cancer 65:118-124